🚀 VC round data is live in beta, check it out!
- Public Comps
- Corbion
Corbion Valuation Multiples
Discover revenue and EBITDA valuation multiples for Corbion and similar public comparables like Anhui Huaheng, CVR Partners, Takara Bio, SunOpta and more.
Corbion Overview
About Corbion
Corbion NV is a Netherlands-based company that produces food ingredients and biobased chemicals. The company distinguishes between the segments Functional Ingredients & Solutions and Health & Nutrition. The Company is a leader in sustainable bio-based ingredients and lactic acid derivatives. The company provides solutions for food preservation, health, and bioplastics through fermentation technology. Its products serve industries including food, pharmaceuticals, personal care, and packaging. Corbion focuses on innovation and sustainability to preserve food, health, and the planet. Geographically, it derives a majority of its revenue from the U.S.
Founded
1903
HQ

Employees
2.4K
Website
Financials (LTM)
EV
$2B
Corbion Financials
Corbion reported last 12-month revenue of $1B and EBITDA of $244M.
In the same LTM period, Corbion generated $419M in gross profit, $244M in EBITDA, and $94M in net income.
Revenue (LTM)
Corbion P&L
In the most recent fiscal year, Corbion reported revenue of $1B and EBITDA of $241M.
Corbion expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $419M | XXX | $382M | XXX | XXX | XXX |
| Gross Margin | 28% | XXX | 26% | XXX | XXX | XXX |
| EBITDA | $244M | XXX | $241M | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | 16% | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $94M | XXX | $88M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 6% | XXX | XXX | XXX |
| Net Debt | — | — | $410M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Corbion Stock Performance
Corbion has current market cap of $1B, and enterprise value of $2B.
Market Cap Evolution
Corbion's stock price is $22.09.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $1B | -0.3% | XXX | XXX | XXX | $1.53 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCorbion Valuation Multiples
Corbion trades at 1.2x EV/Revenue multiple, and 7.4x EV/EBITDA.
EV / Revenue (LTM)
Corbion Financial Valuation Multiples
As of March 24, 2026, Corbion has market cap of $1B and EV of $2B.
Equity research analysts estimate Corbion's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Corbion has a P/E ratio of 13.6x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | 1.2x | XXX | XXX | XXX |
| EV/EBITDA | 7.4x | XXX | 7.4x | XXX | XXX | XXX |
| EV/EBIT | 12.6x | XXX | 12.8x | XXX | XXX | XXX |
| EV/Gross Profit | 4.3x | XXX | 4.7x | XXX | XXX | XXX |
| P/E | 13.6x | XXX | 14.4x | XXX | XXX | XXX |
| EV/FCF | 17.1x | XXX | 16.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Corbion Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Corbion Margins & Growth Rates
Corbion's revenue in the last 12 month grew by 1%.
Corbion's revenue per employee in the last FY averaged $0.6M.
Corbion's rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Corbion's rule of X is 19% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Corbion Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | 0% | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Growth | 5% | XXX | 4% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 17% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 19% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 6% | XXX | 6% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 9% | XXX | 8% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 3% | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 17% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Corbion Public Comps
See public comps and valuation multiples for other Bioindustrials comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Anhui Huaheng | XXX | XXX | XXX | XXX | XXX | XXX |
| CVR Partners | XXX | XXX | XXX | XXX | XXX | XXX |
| Takara Bio | XXX | XXX | XXX | XXX | XXX | XXX |
| SunOpta | XXX | XXX | XXX | XXX | XXX | XXX |
| FMC | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Corbion M&A Activity
Corbion acquired XXX companies to date.
Last acquisition by Corbion was on XXXXXXXX, XXXXX. Corbion acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Corbion
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCorbion Investment Activity
Corbion invested in XXX companies to date.
Corbion made its latest investment on XXXXXXXX, XXXXX. Corbion invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Corbion
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Corbion
| When was Corbion founded? | Corbion was founded in 1903. |
| Where is Corbion headquartered? | Corbion is headquartered in Netherlands. |
| How many employees does Corbion have? | As of today, Corbion has over 2K employees. |
| Is Corbion publicly listed? | Yes, Corbion is a public company listed on Euronext Amsterdam. |
| What is the stock symbol of Corbion? | Corbion trades under CRBN ticker. |
| When did Corbion go public? | Corbion went public in 1984. |
| Who are competitors of Corbion? | Corbion main competitors are Anhui Huaheng, CVR Partners, Takara Bio, SunOpta. |
| What is the current market cap of Corbion? | Corbion's current market cap is $1B. |
| What is the current revenue of Corbion? | Corbion's last 12 months revenue is $1B. |
| What is the current revenue growth of Corbion? | Corbion revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of Corbion? | Current revenue multiple of Corbion is 1.2x. |
| Is Corbion profitable? | Yes, Corbion is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Corbion? | Corbion's last 12 months EBITDA is $244M. |
| What is Corbion's EBITDA margin? | Corbion's last 12 months EBITDA margin is 16%. |
| What is the current EV/EBITDA multiple of Corbion? | Current EBITDA multiple of Corbion is 7.4x. |
| What is the current FCF of Corbion? | Corbion's last 12 months FCF is $105M. |
| What is Corbion's FCF margin? | Corbion's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Corbion? | Current FCF multiple of Corbion is 17.1x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.